KalVista Pharmaceuticals
KALV
KALV
72 hedge funds and large institutions have $194M invested in KalVista Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 18 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
4% more funds holding
Funds holding: 69 → 72 (+3)
0.34% more ownership
Funds ownership: 89.23% → 89.56% (+0.34%)
Holders
72
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$6.81M | |
| 2 | +$2.86M | |
| 3 | +$2.35M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$2.02M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$1.61M |
Top Sellers
| 1 | -$5.28M | |
| 2 | -$4.5M | |
| 3 | -$3.22M | |
| 4 |
Squarepoint
New York
|
-$740K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$715K |